Physician profile
Christine Rohde
NPI 1093733750
$179,825.10
in general payments reported to CMS, 2019-2025
39 companies · $88K in 2025
The $88K reported for 2025 was more than what 99% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $6,095 · 2021: $13K · 2022: $5,836 · 2023: $3,431 · 2024: $52K · 2025: $88K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $96K · Honoraria: $17K · Travel and Lodging: $17K · Food and Beverage: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $95,903.81 |
| Honoraria | $17,475.00 |
| Travel and Lodging | $17,214.21 |
| Food and Beverage | $12,428.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $57,383.42 | 2019-2025 | Dermabond, Stratafix, Dermabond Prineo |
| Davol INC. | $31,467.77 | 2019-2025 | Phasix Mesh, Arista Ah Flexitip, Arista |
| Ethicon Endo-Surgery INC. | $28,386.61 | 2024-2025 | Dermabond |
| Medical Device Business Services, INC. | $21,565.59 | 2019-2025 | |
| Ethicon INC. | $18,175.72 | 2020-2025 | Dermabond |
| Motiva USA, LLC | $3,193.11 | 2024-2025 | |
| Integra Lifesciences Corporation | $2,617.28 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Allergan, INC. | $2,345.41 | 2019-2022 | |
| Polynovo North America LLC | $1,928.41 | 2024-2025 | Novosorb Btm |
| Sientra, INC. | $1,436.80 | 2019-2022 | |
| Mentor Worldwide LLC | $1,418.76 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Siltex Round Spectrum |
| Abbvie INC. | $1,406.17 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm |
| Rti Surgical, INC | $1,371.38 | 2021-2025 | |
| Kci USA, INC. | $1,173.64 | 2019-2023 | Prevena, V.A.C. Veraflo |
| Pacira Pharmaceuticals Incorporated | $628.00 | 2020 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $552.59 | 2021-2024 | |
| Axogen | $551.52 | 2019-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Kerecis Limited | $551.48 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Marigen |
| W. L. Gore & Associates, INC. | $512.49 | 2019-2025 | Gore Enform Preperitoneal Biomaterial |
| Kls-Martin L.P. | $433.09 | 2022 | |
| Avita Medical Americas, LLC | $423.27 | 2023-2025 | Recell, Cohealyx, Permeaderm |
| Medtronic, INC. | $417.33 | 2023-2025 | V-Loc 180, Mazor X System, Biosyn |
| Baxter Healthcare | $254.62 | 2023-2025 | Tisseel |
| Tela Bio, INC. | $233.92 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Becton, Dickinson and Company | $183.43 | 2024-2025 | Phasix Mesh |
| Stryker Corporation | $168.48 | 2024 | Axsos, Pro-Dense |
| Solventum Corporation | $162.65 | 2025 | Prevena, V.A.C. Granufoam, Activ.A.C. |
| Innovation Technologies INC | $149.94 | 2022 | |
| Depuy Synthes Sales INC. | $145.07 | 2025 | Va-Lcp |
| Acell, INC. | $120.27 | 2020 | |
| Coopersurgical, INC. | $118.35 | 2020-2025 | Insorb |
| Checkpoint Surgical, INC | $99.13 | 2022 | |
| Bioventus LLC | $77.91 | 2022 | |
| Sanara Medtech INC. | $67.49 | 2021 | |
| Innocoll Pharmaceuticals Limited | $35.15 | 2023 | Xaracoll |
| Lifenet Health | $24.95 | 2023 | |
| Elutia, INC. | $15.88 | 2021 | |
| Cranial Technologies, INC | $15.57 | 2023 | Doc Band |
| Biocomposites INC | $12.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Rohde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.